Spain Medical Devices Market 2022-2027

    In Stock




    The United States Food and Drug Administration has designated the regulatory category known as “medical device class” (MDC) as its own (FDA). Before and after they are commercially available, medical devices are subject to FDA regulation.

    Infographics-Spain Medical Devices Market , Spain Medical Devices Market Size, Spain Medical Devices Market Trends, Spain Medical Devices Market Forecast, Spain Medical Devices Market Risks, Spain Medical Devices Market Report, Spain Medical Devices Market Share


    The class of a medical device identifies the measures that have been implemented to limit risk and ensure that patients, physicians, and manufacturers can use the equipment in a safe and effective manner. Devices with the lowest danger are classified as Class I, while those with the highest risk are classified as Class III.


    Class I Medical Devices: These products are of a straightforward design and represent little to no risk of illness or injury to users or patients. Oxygen masks, medical gloves, and tongue depressors are a few examples of the gadgets in this area.


    Medical devices classified as Class II have a more complicated design and little chance of causing patients or operators harm or disease. Wheelchairs, X-ray machines, and cardiac monitors are a few examples of the equipment in this category.


    Class III medical devices are those with a complex design that support or maintain human life. Devices in this category have the potential to cause serious damage. Heart valves, pacemakers that are implanted, and brain simulators are some examples of the devices in this category.


    The FDA mandates that Class III devices be created with a delicate balance between user-friendliness and robust cybersecurity measures.




    The Spain Medical Devices marketaccounted for $XX Billion in 2021 and is anticipated to reach $XX Billion by 2026, registering a CAGR of XX% from 2022 to 2027.



    “BD’s new plant in Zaragoza will produce drug delivery devices, primarily for pharmaceutical firms that supply the European market with drugs in pre-fillable syringes such as vaccines and other biologic drugs,” BD Pharmaceutical Systems.


    The high-tech manufacturing facility will be built in Zaragoza, located in the Aragon region of Spain, for an estimated $200 million. The new facility also continues BD’s commitment to Spain, where it began operations more than 40 years ago and currently has three production units situated in San Agustn de Guadalix, Fraga, and Almaraz.


    This new plant will also add essential capacity to support significant immunisation campaigns.


    In order to make its Lenire tinnitus treatment device available in Spain, Irish medical device business Neuromod Devices Ltd., which specialises in the treatment of tinnitus, has entered into a distribution deal with TRUSBIN.


    Clinical experiments have demonstrated that the bimodal neuromodulation device Lenire can lessen tinnitus symptoms. A complex neurological disorder called tinnitus, also known as “ringing in the ears,” causes the perception of sound without an external source. It is estimated that 10-15% of adults worldwide are affected.


    The multidisciplinary team at TRUSBIN has the appropriate expertise and a licence from Neuromod to dispense Lenire in Spain. Lenire will initially be offered in Barcelona, with intentions to increase the device’s accessibility.



    Spain is a key market for medical products, with a population of over 47 million and the fourth-largest economy in the EU. Every Spaniard has access to complete medical care. The majority of medical equipment and supplies are currently purchased by public healthcare facilities, which make up roughly 70% of the healthcare industry. These organizations comprise, among others, public hospitals, health facilities, and research institutes.  


    There is fierce competition from local businesses as well as from the most well-known foreign suppliers, including several American brands that are well-known in the Spanish market. One of the main cornerstones of the NGEU budget, where Spain is one of the top two recipients, is the upgrading of the healthcare system. Medtech efforts like the C18.I1 sector can hold a notable place inside that pillar.


    Due to Spain’s lack of manufacturing capacity to meet that demand, Swiss and other highly developed medtech companies stand to benefit greatly from this situation. Demand for orthopedics, prosthetics, patient aids, home care, hospice items, etc. will increase in the future due to the aging population and the incidence of chronic diseases.


    The rising interest in minimally invasive technologies, particularly in the fields of cardiology and robotics, will be driven by the continued decline in treatment costs. Reputable e-health technologies will continue to be in demand.



    At the start of COVID-19 in 2020, Spain had still not entirely recovered from the devastating effects of the 2007–2013 economic crisis.In Spain, the Covid-19 pandemic restricted access to healthcare, which resulted in a buildup of medical operations (particularly surgery) that were delayed.


    Iberdrola has completed a €22.1 million initial purchase of necessary medical goods in China. These products will be provided to the government once they arrive in Spain. The first contract calls for spending €11.6 million to buy 400 cutting-edge breathing apparatuses. The Ministry of Health will receive the Aeonmed VG70 (Intrusive Oxygen Ventilator) model for distribution.


    The second agreement resulted in the acquisition of 2.5 million FFP2 (KN95) masks. Iberdrola will also contribute 20,000 sets of splash guards, 20,000 pairs of goggles, 50 ORICARE V8800 acute care respirators, 50,000 FFP2 (KN95) masks, and another 50,000 FFP3 masks.


    Spain has a serious issue with outdated technology, according to the nation’s healthcare technology organization, FENIN. It’s anticipated that some of the EU relief money will go toward beginning the equipment’s renovation


    Spain will get million euros from the European Commission to help the country recover from the effects of the virus. Amounts are set aside for a variety of specialized healthcare initiatives, including the hire of additional medical personnel and the purchase of medical equipment, as well as for non-healthcare areas that aim to advance digital transformation. This will contribute to the post-Covid transformation of the Spanish healthcare system.


    Given the necessity for stronger public-private collaboration, particularly in light of the burden put on the system by COVID, the private healthcare sector’s influence continues to grow.




    1. What is the average cost per  Spain Medical Devices market right now and how will it change in next 5-6 years? 
    2. Average cost to set up a  Medical Devices market inSpain?
    3. How many Spain Medical Devices market are manufactured per annum globally? Who are the sub-component suppliers in different regions?
    4. What is happening in the overall public, globally? 
    5. Cost breakup of a  Spain Medical Devices market and key vendor selection criteria
    6. Where is the Spain Medical Devices market manufactured? What is the average margin per equipment?
    7. Market share of Spain Medical Devices market manufacturers and their upcoming products
    8. The most important planned  Spain Medical Devices market in next 2 years
    9. Details on network of major Spain Medical Devices market and pricing plans
    10. Cost advantage for OEMs who manufacture Spain Medical Devices market in-house
    11. 5 key predictions for next 5 years in Title Name
    12. Average B-2-B Spain Medical Devices marketprice in all segments
    13. Latest trends in Title Name, by every market segment
    14. The market size (both volume and value) of Spain Medical Devices marketin 2022-2027 and every year in between?
    15. Global production breakup of Title Name, by suppliers and their OEM relationship




    Sl no Topic
    1 Market Segmentation
    2 Scope of the report
    3 Abbreviations
    4 Research Methodology
    5 Executive Summary
    6 Introduction
    7 Insights from Industry stakeholders
    8 Cost breakdown of Product by sub-components and average profit margin
    9 Disruptive innovation in the Industry
    10 Technology trends in the Industry
    11 Consumer trends in the industry
    12 Recent Production Milestones
    13 Component Manufacturing in US, EU and China
    14 COVID-19 impact on overall market
    15 COVID-19 impact on Production of components
    16 COVID-19 impact on Point of sale
    17 Market Segmentation, Dynamics and Forecast by Geography, 2022-2027
    18 Market Segmentation, Dynamics and Forecast by Product Type, 2022-2027
    19 Market Segmentation, Dynamics and Forecast by Application, 2022-2027
    20 Market Segmentation, Dynamics and Forecast by End use, 2022-2027
    21 Product installation rate by OEM, 2022
    22 Incline/Decline in Average B-2-B selling price in past 5 years
    23 Competition from substitute products
    24 Gross margin and average profitability of suppliers
    25 New product development in past 12 months
    26 M&A in past 12 months
    27 Growth strategy of leading players
    28 Market share of vendors, 2022
    29 Company Profiles
    30 Unmet needs and opportunity for new suppliers
    31 Conclusion
    32 Appendix
      Your Cart
      Your cart is emptyReturn to Shop